Skip to main content
OpenTrials
Completed

NCT Number: NCT00563641

Very Early Surfactant and NCPAP for Premature Infants With RDS

The present study will test the use of very early nasal continuous airway pressure(NCPAP)with and without surfactant in premature infants with clinical evidence or respiratory distress syndrome. We hypothesize that premature infants exposed to very early NCPAP and surfactant will require less mechanical ventilation compared to those premature infants exposed to NCPAP alone.

Completed

Looking for future studies?

Notify Me

Key information

Age range

27 week–31 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Department of Epidemiology and Biostatistics Pontificia Universidad Javeriana

Bogota, Cundinamarca, Colombia

About this study

Premature infants who are not intubated during the first 15 minutes of life and who develop clinical evidence of respiratory distress or need for oxygen requirement between 15 and 60 minutes of life, will be placed on bubble NCPAP of 6 cm H2O. Randomization envelops will them be opened and patients will be assigned to continuation on NCPAP alone (Control Group) or to NCPAP plus very early surfactant therapy (Treatment Group). Patients assigned to the treatment group will be transiently intubated for surfactant administration, extubated, and placed back on NCPAP of 6 cm H2O. Both groups will then be followed over time to determine which infants meet treatment failure criteria defined as: Treatment failure was defined a priori by either failure of adequate oxygenation or ventilation as follows: "1" FiO2 greater than 0.75 for more than 30 minutes to maintain SpO2 within the pre-established target ranges, "2" persistent or recurrent desaturation below 80% that did not respond to suctioning of the airways and PPV, "3" PCO2>65 mmHg and pH<7.22 on an arterial or capillary blood gas analysis, in association with increased work of breathing. Infants in the Treatment Group who cannot be extubated after their initial dose of surfactant because of clinical instability will be analyzed as treatment failures. Premature infants that meet treatment failure criteria on either arm will be intubated and placed on mechanical ventilation and given surfactant rescue doses according to the criteria of the participating institutions. Premature infants with respiratory distress syndrome who do not meet treatment failure criteria in both groups will remain on NCPAP until their respiratory failure improves.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gestational age of 27 to 31 6/7 weeks,
  • Postnatal age between 15 and 60 minutes,
  • Supplemental oxygen requirement or evidence of increased work of breathing (tachypnea, intercostal retractions, nasal flaring, or grunting), and
  • Prenatal consent.

Exclusion criteria

  • Apgar score less than 2 at 5 minutes,
  • Intubation prior to randomization,
  • Prenatal diagnosis of major congenital anomalies,
  • Prolonged rupture of membranes of greater than 3 weeks duration, and
  • Infants who were likely to be transferred to another center soon after birth were not enrolled in the study.

Treatment and study plan

Very early surfactant and bubble NCPAP

Other

For patients randomized to early NCPAP plus surfactant, 4ml/kg of surfactant were administered through an endotracheal tube in two aliquots, 2 minutes apart followed by positive pressure ventilation administered for one minute with a Neopuff Infant Resuscitator pre-set to give a peak pressure of 20 cm H2O and 5 cm H2O of positive end expiratory pressure. Infant was then extubated and placed on NCPAP of 6 cmH2O

bubble NCPAP

Other

Premature infants randomized to bubble NCPAP alone will continue on NCPAP until they reach "yes or no" treatment failure criteria.

Primary outcomes

  1. Need for mechanical ventilation

    Time frame: Death or discharge from the NICU

Secondary outcomes

  1. Neonatal mortality

    Time frame: During hospitalization in the NICU

  2. Air leak syndrome

    Time frame: death or discharge from the NICU

  3. Oxygen dependency at 36 weeks post menstrual age

    Time frame: Death or discharge from the NICU

Sponsors and collaborators

Lead sponsor

Colombian Neonatal Research Network

Other

Collaborators

  • Abbott
  • Fisher and Paykel Healthcare
  • Pontificia Universidad Javeriana
  • Vanderbilt University School of Medicine

Registry information

Official study title

Very Early Surfactant Without Mandatory Ventilation In Premature Infants Treated With Early Continuous Positive Airway Pressure-A Randomized Controlled Trial

Acronym: CNRNCPAP

Important dates

Study start
2004
Study completion
2006
First posted
Nov 26, 2007
Registry last updated
Nov 26, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.